01). Robert WB., James DH. Rockwood and Green' s fractures in adults,. 5th ed.Philadelphia: Lippincott Williams & Wilkins;p. 557–578. 2001.
02). Kim DH., Silber JS., Albert TJ. Osteoporotic vertebral compression fracture. Instructional Course Lectures. 52. Rosemont IL: American academy of orthopaedic surgeons;p. 541–550. 2003.
03). Daldrup-Link HE., Franzius C., Link TM., Laukamp D., Sciuk J., Jurgens H., Schober O., Rummeny EJ. Whole-body MR imaging for detection of bone metastases in chil-dren and young adults: comparison with skeletal scintigraphy and FDG-PET. Am J Roentgenol. 2001. 177:229–236.
04). Carrage EJ. The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis. Spine. 1997. 22(7):780–785.
Article
05). Boutin RD. Musculoskeletal imaging update, part II: update on imaging orthopedic infections. Ortho Clin North Am. 1998. 29(1):41–66.
06). Vaccaro AR., Betz RR., Zeidman SM. Principle and practice of spinal surgery. Philadelphia: Mosby;p. 165–222. 2003.
07). Seong KH., Byun WM., Lee JK., Cho JH., Cho KH., Hwang MS., Park BH., Suh KJ. Differentiation between Osteoporotic and Metastatic Vertebral Compression Fractures by MRI. J Kor Rad Soc. 1997. 37(3):529–534.
Article
08). Ghanem N., Uhl M., Brink I., Schafer O., Kelly T., Moser E., Langer M. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for detection of metastasis of bone. Eur J Radiology. 2005. 55:41–55.
09). Gustav K. Clinical Molecular Anatomic Imaging. Philadelphia: Lippincott Williams & Wilkins;p. 251–270. 412-428. 2003.
10). Bombardieri E., Crippa F. The increasing impact of PET in the diagnostic work-up of cancer, Nuclear medicine annual 2002. Philadelphia: Lippincott Williams & Wilkins;p. 75–121. 2002.
11). Schmitz A., Risse JH., Textor J., Zander D., Biersack HJ., Schmitt O., Palmedo H. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoposos Int. 2002. 13:755–761.
Article
12). Chung JK. Mechanisms of Glucose Uptake in Cancer Tissue. Kor J Nucl Med. 1999 Feb. 33(1):1–10.
13). Metser U., Metser U., Lerman H., Blank A., Lievshitz G., Bokstein F., Even-Sapir E. Malignant involvement of the spine; assessment by 18F-FDG PET/CT. J Nucl Med. 2004. 45(2):279–284.
14). Bohdiewicz PJ., Wong CY., Kondas D., Gaskill M., Dworkin HJ. High predictive value of F-18 FDG PET patterns of the spine for metastasis or benign lesions with good agreement between readers. Clin Nucl Med. 2003. 28(12):966–970.
15). Seo JG., Oh WH., Kim TH., Kim BT. A preliminary Analysis of FDG-PET Findings in Musculoskeletal Tumors. J Kor Bone and Joint Tumor Soc? 1996. 2(2):186–193.
16). Yamada S., Kubota K., Kubota R., Ido T., Tamahashi N. High accumulation of fluorine 18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995. 36:1301–1306.
17). Stumpe KD., Dazzi H., Schaffner A., von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000. 27(7):822–832.
Article
18). Gratz S., Do¨ rner J., Fischer U., Behr TM., Behe M., Altenvoerde G., Meller J., Grabbe E., Becker W. 18 F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med. 2002. 29(4):516–523.
19). Schmitz A., Risse JH., Gru¨ nwald F., Gassel F., Biersack HJ., Schmitt O. Fluorine-18 fluorodeoxyglucose postron emission tomography findings in spondylodiscitis: preliminary results. Eur Spine J. 2001. 10:534–539.